These final results, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,two help the strategy of targeting ACKR3 as a unique solution to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Conditions.We independently research, overview, and end